First Time Loading...

Zymeworks Inc
NYSE:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NYSE:ZYME
Watchlist
Price: 9.15 USD
Updated: May 16, 2024

Zymeworks Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zymeworks Inc
Research & Development Peer Comparison

Comparables:
TH
RPTX
FUSN
AUPH
EDT

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Zymeworks Inc
NYSE:ZYME
Research & Development
-$143.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Research & Development
-$24.8m
CAGR 3-Years
-8%
CAGR 5-Years
-24%
CAGR 10-Years
-14%
Repare Therapeutics Inc
NASDAQ:RPTX
Research & Development
-$131.8m
CAGR 3-Years
-50%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Research & Development
-$70.1m
CAGR 3-Years
-60%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Research & Development
-$42m
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
-32%
Spectral Medical Inc
TSX:EDT
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zymeworks Inc's Research & Development?
Research & Development
-143.7m USD

Based on the financial report for Dec 31, 2023, Zymeworks Inc's Research & Development amounts to -143.7m USD.

What is Zymeworks Inc's Research & Development growth rate?
Research & Development CAGR 1Y
31%

Over the last year, the Research & Development growth was 31%.